NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Scott J Antonia
Duke University - Durham / United States
Others
AD Scientific Index ID: 1293655
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Scott J Antonia's MOST POPULAR ARTICLES
1-)
Safety, activity, and immune correlates of anti–PD-1 antibody in cancerSL Topalian, FS Hodi, JR Brahmer, SN Gettinger, DC Smith, ...New England Journal of Medicine 366 (26), 2443-2454, 2012122882012
2-)
Nivolumab versus docetaxel in advanced nonsquamous non–small-cell lung cancerH Borghaei, L Paz-Ares, L Horn, DR Spigel, M Steins, NE Ready, ...New England Journal of Medicine 373 (17), 1627-1639, 201582682015
3-)
Nivolumab versus docetaxel in advanced squamous-cell non–small-cell lung cancerJ Brahmer, KL Reckamp, P Baas, L Crinò, WEE Eberhardt, ...New England Journal of Medicine 373 (2), 123-135, 201577012015
4-)
Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancerSJ Antonia, A Villegas, D Daniel, D Vicente, S Murakami, R Hui, T Yokoi, ...New England Journal of Medicine 377 (20), 1919-1929, 201743872017
5-)
Overall survival with durvalumab after chemoradiotherapy in stage III NSCLCSJ Antonia, A Villegas, D Daniel, D Vicente, S Murakami, R Hui, T Kurata, ...New England Journal of Medicine 379 (24), 2342-2350, 201828142018
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept